Read More

Synlogic Adopts Limited Duration Stockholders Rights Plan And Authorized A Dividend Distribution Of One Right For Each Outstanding Share Of Common Stock; Effective Immediately And Has A 1-Year Duration, Expiring On February 20, 2025

Synlogic, Inc. (NASDAQ:SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today announced that its Board of Directors (the "Board") has approved the adoption of a

SYBX